Variant report

Variant	nsv960442
Chromosome Location	chr17:20901168-20903702
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:267)
CpG islands
(count:61)
Chromatin interactive
region (count:9)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:267 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:20901306-20901473	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr17:20902875-20903089	K562	blood:	n/a	n/a
3	BCL3	chr17:20902179-20902531	K562	blood:	n/a	n/a
4	BCL3	chr17:20901037-20901284	GM12878	blood:	n/a	n/a
5	BCL3	chr17:20900407-20902753	A549	lung:	n/a	n/a
6	BCL3	chr17:20901646-20902196	GM12878	blood:	n/a	n/a
7	BCL3	chr17:20900503-20902569	A549	lung:	n/a	n/a
8	BCLAF1	chr17:20901700-20902142	GM12878	blood:	n/a	n/a
9	BCLAF1	chr17:20901800-20902496	GM12878	blood:	n/a	n/a
10	BRCA1	chr17:20901757-20901855	H1-hESC	embryonic stem cell:	n/a	n/a
11	CHD2	chr17:20901958-20902159	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD2	chr17:20902362-20902741	HepG2	liver:	n/a	n/a
13	CHD2	chr17:20902049-20902059	GM12878	blood:	n/a	n/a
14	CHD2	chr17:20901355-20901626	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr17:20901714-20901771	Hela-S3	cervix:	n/a	n/a
16	CTCF	chr17:20901400-20901550	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr17:20901344-20901500	K562	blood:	n/a	n/a
18	CTCF	chr17:20901060-20901210	GM12867	blood:	n/a	n/a
19	CTCF	chr17:20901471-20901489	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr17:20901345-20901497	GM12892	blood:	n/a	n/a
21	CTCF	chr17:20901320-20901470	HEK293	kidney:	n/a	n/a
22	CTCF	chr17:20901128-20901236	NHEK	skin:	n/a	n/a
23	CTCF	chr17:20901354-20901496	Hela-S3	cervix:	n/a	n/a
24	CTCF	chr17:20901369-20901527	SK-N-SH_RA	brain:	n/a	n/a
25	CTCF	chr17:20901365-20901496	SK-N-SH_RA	brain:	n/a	n/a
26	CTCF	chr17:20901046-20901221	Hela-S3	cervix:	n/a	n/a
27	CTCF	chr17:20901100-20901250	GM12864	blood:	n/a	n/a
28	CTCF	chr17:20901366-20901476	GM19239	blood:	n/a	n/a
29	CTCF	chr17:20901437-20901464	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr17:20901361-20901515	NHEK	skin:	n/a	n/a
31	CTCF	chr17:20903360-20903510	NB4	blood:	n/a	n/a
32	CTCF	chr17:20901067-20901546	GM12878	blood:	n/a	n/a
33	CTCF	chr17:20901068-20901173	GM19240	blood:	n/a	n/a
34	CTCF	chr17:20901062-20901206	GM12892	blood:	n/a	n/a
35	CTCF	chr17:20901044-20901195	GM12891	blood:	n/a	n/a
36	CTCF	chr17:20901360-20901510	A549	lung:	n/a	n/a
37	CTCF	chr17:20901363-20901466	HepG2	liver:	n/a	n/a
38	CTCF	chr17:20901420-20901570	AG04449	skin:	n/a	n/a
39	CTCF	chr17:20901369-20901490	GM19238	blood:	n/a	n/a
40	CTCF	chr17:20901070-20901236	MCF-7	breast:	n/a	n/a
41	CTCF	chr17:20901180-20901330	AG04449	skin:	n/a	n/a
42	CTCF	chr17:20901405-20901429	Kidney_OC	kidney:	n/a	n/a
43	CTCF	chr17:20901081-20901185	GM19239	blood:	n/a	n/a
44	CTCF	chr17:20901400-20901550	HFF-Myc	foreskin:	n/a	n/a
45	CTCF	chr17:20901300-20901450	WERI-Rb-1	eye:	n/a	n/a
46	CTCF	chr17:20900989-20901275	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr17:20901220-20901370	GM12864	blood:	n/a	n/a
48	CTCF	chr17:20901060-20901210	HEK293	kidney:	n/a	n/a
49	CTCF	chr17:20903120-20903270	Caco-2	colon:	n/a	n/a
50	CTCF	chr17:20901320-20901470	HepG2	liver:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20903244-20903294	PFSK-1	brain:	n/a
2	chr17:20903244-20903294	HL-60	blood:	n/a
3	chr17:20903244-20903294	HCF	heart:	n/a
4	chr17:20903244-20903294	GM12891	blood:	n/a
5	chr17:20903244-20903294	PANC-1	pancreas:	n/a
6	chr17:20903244-20903294	IMR90	lung:	fetal
7	chr17:20903244-20903294	LNCaP	prostate:	n/a
8	chr17:20903244-20903294	Hela-S3	cervix:	n/a
9	chr17:20903244-20903294	Hepatocyte	liver:	n/a
10	chr17:20903244-20903294	HEK293	kidney:	embryo
11	chr17:20903244-20903294	GM12892	blood:	n/a
12	chr17:20903244-20903294	NHDF-neo	bronchial:	n/a
13	chr17:20903244-20903294	NHBE	bronchial:	n/a
14	chr17:20903244-20903294	HRPEpiC	eye:	n/a
15	chr17:20903244-20903294	GM06990	blood:	n/a
16	chr17:20903244-20903294	SKMC	muscle:	n/a
17	chr17:20903244-20903294	AG09309	skin:	n/a
18	chr17:20903244-20903294	SK-N-SH	brain:	n/a
19	chr17:20903244-20903294	GM19239	blood:	n/a
20	chr17:20903244-20903294	SK-N-MC	brain:	n/a
21	chr17:20903244-20903294	HEEpiC	esophagus:	n/a
22	chr17:20903244-20903294	T-47D	breast:	n/a
23	chr17:20903244-20903294	HepG2	liver:	n/a
24	chr17:20903244-20903294	AG04450	lung:	fetal
25	chr17:20903244-20903294	HCT-116	colon:	n/a
26	chr17:20903244-20903294	HNPCEpiC	eye:	n/a
27	chr17:20903244-20903294	AG09319	gingival:	n/a
28	chr17:20903244-20903294	HPAEpiC	pulmonary alveolar:	n/a
29	chr17:20903244-20903294	SAEC	small airway:	n/a
30	chr17:20903244-20903294	SK-N-SH_RA	brain:	n/a
31	chr17:20903244-20903294	ProgFib	skin:	n/a
32	chr17:20903244-20903294	MCF-7	breast:	n/a
33	chr17:20903244-20903294	BE2_C	brain:	n/a
34	chr17:20903244-20903294	A549	lung:	n/a
35	chr17:20903244-20903294	ECC-1	luminal epithelium:	n/a
36	chr17:20903244-20903294	GM12878	blood:	n/a
37	chr17:20903244-20903294	ovcar-3	ovarian:	n/a
38	chr17:20903244-20903294	HMEC	breast:	n/a
39	chr17:20903244-20903294	NB4	blood:	n/a
40	chr17:20903244-20903294	HAEpiC	amniotic membrane:	n/a
41	chr17:20903244-20903294	CMK	blood:	n/a
42	chr17:20903244-20903294	Caco-2	colon:	n/a
43	chr17:20903244-20903294	HUVEC	blood vessel:	n/a
44	chr17:20903244-20903294	HRE	kidney:	n/a
45	chr17:20903244-20903294	NH-A	brain:	n/a
46	chr17:20903244-20903294	AoSMC	blood vessel:	n/a
47	chr17:20903244-20903294	PrEC	prostate:	n/a
48	chr17:20903244-20903294	BJ	skin:	n/a
49	chr17:20903244-20903294	AG04449	skin:	fetal
50	chr17:20903244-20903294	U87	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:20899990..20902443-chr17:20946128..20948088,2	K562	blood:
2	chr17:20903402..20905439-chr17:20907527..20910856,3	K562	blood:
3	chr17:20815505..20817984-chr17:20903354..20904947,2	MCF-7	breast:
4	chr17:20903595..20905991-chr17:20912235..20915117,2	MCF-7	breast:
5	chr17:20902261..20904753-chr17:20906540..20909495,2	MCF-7	breast:
6	chr17:20901201..20904612-chr17:20905901..20908917,4	MCF-7	breast:
7	chr17:20893363..20896072-chr17:20898999..20901703,2	MCF-7	breast:
8	chr17:20900050..20901935-chr17:20907536..20910241,2	MCF-7	breast:
9	chr17:20903178..20905982-chr17:20906732..20909453,3	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHRS7B-3	chr17:20903424-20903636	ENSG00000263986.1
2	lnc-DHRS7B-3	chr17:20903060-20903350	ENSG00000263986.1
3	lnc-DHRS7B-5	chr17:20901139-20901341	ENSG00000233098.3

No data

Variant related genes	Relation type
ENSG00000263986	TF binding region
ENSG00000263986	CpG island
ENSG00000124422	chromatin interactions

Extended variants
information (count: 129 )
Associated
traits (count: 149 )

Variant overlapped rSNPs/rCNVs (count:129 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116607165	chr17:20901195-20901196	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
2	rs372851269	chr17:20901224-20901225	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs546678559	chr17:20901240-20901241	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
4	rs4985815	chr17:20901247-20901248	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs112327161	chr17:20901263-20901264	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
6	rs138320939	chr17:20901264-20901265	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
7	rs551022621	chr17:20901285-20901286	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
8	rs111932850	chr17:20901312-20901313	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
9	rs572970707	chr17:20901352-20901353	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs149571082	chr17:20901374-20901375	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs533546444	chr17:20901385-20901386	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs536916118	chr17:20901405-20901406	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs191032040	chr17:20901410-20901411	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs143225248	chr17:20901414-20901415	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs534759230	chr17:20901438-20901439	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs369852815	chr17:20901439-20901440	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs545658380	chr17:20901450-20901451	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs565461830	chr17:20901453-20901454	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs2009756	chr17:20901464-20901465	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs567607156	chr17:20901466-20901467	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs2009757	chr17:20901485-20901486	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs138797196	chr17:20901528-20901529	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs182977024	chr17:20901589-20901590	Weak transcription Genic enhancers Strong transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs186646724	chr17:20901606-20901607	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs142055563	chr17:20901611-20901612	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs560986928	chr17:20901642-20901643	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs115344578	chr17:20901644-20901645	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs546715378	chr17:20901654-20901655	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs75558224	chr17:20901668-20901669	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs4985816	chr17:20901713-20901714	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs530049277	chr17:20901724-20901725	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs76709877	chr17:20901731-20901732	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs11869271	chr17:20901758-20901759	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs536989183	chr17:20901759-20901760	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs191057047	chr17:20901790-20901791	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs116399560	chr17:20901830-20901831	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs534586996	chr17:20901861-20901862	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs371845948	chr17:20901881-20901882	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs577690601	chr17:20901897-20901898	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs538308934	chr17:20901911-20901912	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs557129275	chr17:20901917-20901918	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs146320022	chr17:20901928-20901929	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs542559302	chr17:20901954-20901955	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs554420999	chr17:20901964-20901965	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs572934602	chr17:20901975-20901976	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs540635859	chr17:20901983-20901984	Weak transcription Enhancers Genic enhancers Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs35115864	chr17:20902010-20902011	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs565104449	chr17:20902054-20902055	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs532640054	chr17:20902063-20902064	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs111354420	chr17:20902071-20902072	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:149)

Disease	PMID	Source
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Autism	20808228	CNVD

Chromatin state (count:279 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20893000-20901600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
2	chr17:20893800-20901200	Weak transcription	Right Atrium	heart
3	chr17:20896400-20901400	Weak transcription	Duodenum Smooth Muscle	Duodenum
4	chr17:20896400-20901600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr17:20896400-20902800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
6	chr17:20896600-20901800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr17:20896600-20901800	Weak transcription	HUVEC	blood vessel
8	chr17:20896600-20902000	Weak transcription	Primary T helper cells PMA-I stimulated	--
9	chr17:20896600-20906800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
10	chr17:20896800-20901400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr17:20896800-20901400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
12	chr17:20896800-20901400	Weak transcription	Fetal Lung	lung
13	chr17:20896800-20901600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr17:20896800-20901600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr17:20896800-20901600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
16	chr17:20896800-20901600	Weak transcription	HSMM	muscle
17	chr17:20896800-20901800	Weak transcription	Primary T helper cells fromperipheralblood	blood
18	chr17:20896800-20901800	Weak transcription	Muscle Satellite Cultured Cells	--
19	chr17:20896800-20901800	Weak transcription	NHDF-Ad	bronchial
20	chr17:20896800-20902200	Weak transcription	Primary B cells from peripheral blood	blood
21	chr17:20896800-20902200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr17:20896800-20902200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr17:20896800-20902200	Weak transcription	Fetal Thymus	thymus
24	chr17:20896800-20902400	Weak transcription	H9 Cell Line	embryonic stem cell
25	chr17:20896800-20902600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
26	chr17:20896800-20902600	Weak transcription	Colonic Mucosa	Colon
27	chr17:20896800-20902600	Weak transcription	Rectal Mucosa Donor 29	rectum
28	chr17:20896800-20902600	Weak transcription	NHEK	skin
29	chr17:20896800-20904200	Weak transcription	Primary T cells from cord blood	blood
30	chr17:20896800-20904800	Weak transcription	Fetal Kidney	kidney
31	chr17:20896800-20905200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr17:20897000-20901200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr17:20897000-20901600	Weak transcription	HSMMtube	muscle
34	chr17:20897000-20901800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr17:20897000-20901800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr17:20897000-20901800	Weak transcription	HUES48 Cell Line	embryonic stem cell
37	chr17:20897000-20901800	Weak transcription	Fetal Heart	heart
38	chr17:20897000-20901800	Weak transcription	Rectal Smooth Muscle	rectum
39	chr17:20897000-20902000	Weak transcription	HUES64 Cell Line	embryonic stem cell
40	chr17:20897000-20902000	Weak transcription	Osteobl	bone
41	chr17:20897000-20902400	Weak transcription	HMEC	breast
42	chr17:20897000-20902600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
43	chr17:20897000-20902600	Weak transcription	Cortex derived primary cultured neurospheres	brain
44	chr17:20897000-20902600	Weak transcription	Pancreas	Pancrea
45	chr17:20897000-20902800	Weak transcription	HepG2	liver
46	chr17:20897000-20903400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
47	chr17:20897000-20905200	Weak transcription	Fetal Brain Male	brain
48	chr17:20897200-20901800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
49	chr17:20897200-20902000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr17:20897200-20904600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links